Psychedelic medicines
Coverage of Psychedelic medicines in the Nexus archive.
- Opinion: Trump’s executive order on psychedelics is the right move. But is my field ready for it?
President Trump signed an executive order on psychedelic medicines to accelerate approval timelines and expand research. The order directs the Food and Drug Administration to issue priority review vouchers and dedicates $50 million in ARPA-H funding to psychedelic research. The move aims to develop novel treatments for mental health conditions.
- Trump’s experiment with psychedelic medicines
The article discusses U.S. President Donald Trump's exploration of psychedelic medicines, highlighting potential therapeutic uses and regulatory challenges. It is featured in the latest issue of The Economist, which often covers such topics.
- Donald Trump is giving psychedelic medicines a welcome boost
Donald Trump is supporting psychedelic medicines, but concerns remain about the potential negative impact of his methods.
- The debate about whether the NHS should use magic mushrooms to treat depression
The NHS is debating the use of magic mushrooms for depression treatment. Clinical trials since 2022 have shown promising results for psychedelic medicines in treating depression. The discussion highlights potential breakthroughs in mental health care.